CSIMarket
 


Venus Concept Inc   (VERO)
Other Ticker:  
 
 

VERO's Revenue Growth by Quarter and Year

Venus Concept Inc 's Revenue results by quarter and year




VERO Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.31 37.59 25.83
III Quarter September 13.19 14.59 24.56 20.68
II Quarter June 15.22 28.30 25.83 17.00
I Quarter March 15.21 27.33 22.60 14.51
FY   43.62 70.53 110.58 78.02



VERO Revenue third quarter 2023 Y/Y Growth Comment
Venus Concept Inc reported decrease in Revenue in the third quarter 2023 by -9.63% to $ 13.19 millions, from the same quarter in 2022.
The decrease in the third quarter 2023 Venus Concept Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 115.16%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 111 other companies have achieved higher Revenue growth. While Venus Concept Inc ' s Revenue decline of -9.63% ranks overall at the positon no. 2244 in the third quarter 2023.




VERO Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -99.18 % 45.53 % -73.85 %
III Quarter September -9.63 % -40.59 % 18.76 % 524.77 %
II Quarter June -46.22 % 9.56 % 51.94 % 480.2 %
I Quarter March -44.35 % 20.93 % 55.75 % 169.2 %
FY   - -36.22 % 41.73 % -29.33 %

Financial Statements
Venus Concept Inc 's third quarter 2023 Revenue $ 13.19 millions VERO's Income Statement
Venus Concept Inc 's third quarter 2022 Revenue $ 14.59 millions Quarterly VERO's Income Statement
New: More VERO's historic Revenue Growth >>


VERO Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -97.88 % 53.05 % 24.9 %
III Quarter September -13.37 % -48.45 % -4.92 % 21.65 %
II Quarter June 0.07 % 3.55 % 14.29 % 17.16 %
I Quarter March 4806.45 % -27.29 % -12.5 % -85.31 %
FY (Year on Year)   - -36.22 % 41.73 % -29.33 %




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #112
Healthcare Sector #362
Overall #2244

Revenue Y/Y Growth Statistics
High Average Low
725.36 % 115.16 % -61.51 %
(Sep 30 2020)   (Jun 30 2023)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #112
Healthcare Sector #362
Overall #2244
Revenue Y/Y Growth Statistics
High Average Low
725.36 % 115.16 % -61.51 %
(Sep 30 2020)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Venus Concept Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
4789.71 % 341.15 % -97.87 %
(Mar 31 2023)  


VERO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Venus Concept Inc realized drop in Revenue sequentially by -13.37% to $ 13.19 millions, from $ 15.22 millions released in the previous quarter.

When you analyse present slump in the III. Quarter 2023, you must presume, that commonly III. Quarter Revenue appear to be weaker relative to the preciding period

Within Medical Equipment & Supplies industry 117 other companies have achieved higher Revenue quarter on quarter growth. While Venus Concept Inc 's Revenue growth quarter on quarter, overall rank is 2802.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #118
Healthcare Sector #416
Overall #2802
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #118
Healthcare Sector #416
Overall #2802
Revenue Q/Q Growth Statistics
High Average Low
4789.71 % 341.15 % -97.87 %
(Mar 31 2023)  


VERO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2023 Venus Concept Inc realized drop in Revenue from the previous quarter by -13.37% to $ 13.19 millions, from $ 15.22 millions achived a quarter before.

This is not big problem, as Venus Concept Inc 's Revenue frequently seem to slow in the III. Quarter Diego Colombo, Medical Equipment & Supplies industry observer allocated in Rome noted.

Within Medical Equipment & Supplies industry 117 other companies have achieved higher Revenue quarter on quarter growth. While Venus Concept Inc 's Revenue growth quarter on quarter, overall rank is 2802.


Venus Concept Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 43.92 $ 45.33 $ 58.41 $ 70.53 $ 107.81
Y / Y Revenue Growth (TTM) -59.26 % -61.51 % -49.34 % -36.21 % 9.1 %
Year on Year Revenue Growth Overall Ranking # 1435 # 781 # 501 # 0 # 1468
Seqeuential Revenue Change (TTM) -3.1 % -22.39 % -17.19 % -34.58 % -8.47 %
Seq. Revenue Growth (TTM) Overall Ranking # 2768 # 2354 # 1405 # 0 # 2318




Cumulative Revenue growth Comment
Venus Concept Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Venus Concept Inc 's annual Revenue decrease would be -59.26% year on year to $44 millions.

In the Healthcare sector 277 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 781 to 1435.

Revenue TTM Q/Q Growth Statistics
High Average Low
725.36 %
115.16 %
-61.51 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 278
Overall # 1435

Revenue TTM Y/Y Growth Statistics
High Average Low
725.36 %
115.16 %
-61.51 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 431
S&P 500 # 2768
Cumulative Revenue growth Comment
Venus Concept Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Venus Concept Inc 's annual Revenue drop would be -59.26% year on year to $44 millions.

In the Healthcare sector 277 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 781 to 1435.

Revenue TTM Q/Q Growth Statistics
High Average Low
725.36 %
115.16 %
-61.51 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 278
Overall # 1435

Revenue TTM Y/Y Growth Statistics
High Average Low
725.36 %
115.16 %
-61.51 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 431
S&P 500 # 2768




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VERO's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for VERO's Competitors
Revenue Growth for Venus Concept Inc 's Suppliers
Revenue Growth for VERO's Customers

You may also want to know
VERO's Annual Growth Rates VERO's Profitability Ratios VERO's Asset Turnover Ratio VERO's Dividend Growth
VERO's Roe VERO's Valuation Ratios VERO's Financial Strength Ratios VERO's Dividend Payout Ratio
VERO's Roa VERO's Inventory Turnover Ratio VERO's Growth Rates VERO's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Procyon Corporation-0.22%$ -0.221 millions
Amedisys Inc -0.31%$ -0.314 millions
Karyopharm Therapeutics Inc -0.38%$ -0.376 millions
Establishment Labs Holdings Inc -0.50%$ -0.505 millions
Opko Health Inc -0.64%$ -0.639 millions
Integra Lifesciences Holdings Corp-0.72%$ -0.719 millions
Healthcare Services Group Inc -0.75%$ -0.748 millions
Phibro Animal Health Corporation-0.77%$ -0.772 millions
Bellicum Pharmaceuticals Inc -0.89%$ -0.890 millions
Prestige Consumer Healthcare Inc -1.12%$ -1.125 millions
Sharecare Inc -1.13%$ -1.127 millions
Lifevantage Corp-1.14%$ -1.140 millions
Organon and Co -1.17%$ -1.171 millions
Optinose Inc -1.27%$ -1.270 millions
Baxter International Inc -1.72%$ -1.723 millions
Puma Biotechnology Inc -1.73%$ -1.727 millions
Blueprint Medicines Corporation-1.76%$ -1.763 millions
Standard Biotools Inc -1.92%$ -1.918 millions
Pacira Biosciences inc -2.11%$ -2.114 millions
Bristol myers Squibb Company-2.25%$ -2.246 millions
Aurinia Pharmaceuticals Inc -2.27%$ -2.266 millions
Abbott Laboratories-2.56%$ -2.565 millions
Enhabit Inc -2.79%$ -2.785 millions
Novocure Limited-2.81%$ -2.807 millions
Uniqure N v -2.90%$ -2.899 millions
Vaso Corporation-2.92%$ -2.925 millions
Scientific Industries Inc -3.16%$ -3.165 millions
Akumin Inc -3.21%$ -3.205 millions
Syros Pharmaceuticals Inc -3.32%$ -3.315 millions
Viatris Inc -3.34%$ -3.342 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com